Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Moving claims forward during COVID-19 - Guidelines
In the face of a crisis, the workers’ comp community has historically pulled together to overcome whatever obstacle that’s come our way.
Workers' Comp
Article
Meeting Your Needs Through Hurricane Florence
As Hurricane Florence approaches the East Coast, we want you to know you will have access to Genex’s services at all times.
Mitchell
News Release
Impact of COVID-19 on Workers' Compensation and Auto Casualty Industries
Mitchell
News Release
State-By-State Pharmacy Rule Updates Related to COVID-19
In the wake of COVID-19, a number of states have begun relaxing time frames and other rules around the provision of care for their citizens, includ
Auto Casualty
Article
Five Questions With Shahin Hatamian on How to Incorporate More Automation in the Claims Process
We sat down with Mitchell Senior Vice President, Shahin Hatamian, to discuss how claims organizations can utilize automation to help expedite proce
Mitchell
News Release
New York Updates Workers' Comp Drug Formulary
The New York State Workers' Compensation Board announced updates to its drug formulary, effective April 1, 2020.